PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy.
Journal
NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891
Informations de publication
Date de publication:
05 May 2021
05 May 2021
Historique:
received:
11
11
2019
accepted:
12
11
2020
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
7
5
2021
Statut:
epublish
Résumé
Clinicopathological prognostic features have limited value to identify with precision newly diagnosed patients with hormone receptor (HR)-positive, HER2-negative breast cancer (BC), who would benefit from chemotherapy (CT) in addition to adjuvant hormonal therapy (HT). The 21-gene Oncotype DX Breast Recurrence Score
Identifiants
pubmed: 33953182
doi: 10.1038/s41523-021-00246-4
pii: 10.1038/s41523-021-00246-4
pmc: PMC8099872
doi:
Types de publication
Journal Article
Langues
eng
Pagination
47Références
Oncologist. 2018 Mar;23(3):297-305
pubmed: 29133514
Curr Med Res Opin. 2016 Jul;32(7):1217-24
pubmed: 26971372
PLoS One. 2017 Oct 18;12(10):e0185753
pubmed: 29045452
Oncologist. 2018 Jul;23(7):768-775
pubmed: 29371476
Med J Aust. 2013 Aug 5;199(3):205-8
pubmed: 23909545
Breast Cancer Res Treat. 2019 Jun;175(2):389-399
pubmed: 30796651
N Engl J Med. 2015 Nov 19;373(21):2005-14
pubmed: 26412349
J Natl Cancer Inst. 2013 Dec 18;105(24):1897-906
pubmed: 24203987
J Natl Compr Canc Netw. 2018 Nov;16(11):1362-1389
pubmed: 30442736
NPJ Breast Cancer. 2018 Aug 20;4:27
pubmed: 30155517
J Natl Cancer Inst. 2014 Apr 28;106(5):
pubmed: 24777111
Breast Cancer Res Treat. 2017 Jun;163(2):303-310
pubmed: 28243896
NPJ Breast Cancer. 2016 Jun 08;2:16017
pubmed: 28721379
J Natl Cancer Inst. 2008 Feb 6;100(3):207-12
pubmed: 18230798
J Med Econ. 2012;15(6):1167-75
pubmed: 22853442
Bull Cancer. 2011 Jul;98(7):E69-79
pubmed: 21684837
NPJ Breast Cancer. 2018 Nov 14;4:37
pubmed: 30456299
Lancet. 2012 Feb 4;379(9814):432-44
pubmed: 22152853
J Clin Oncol. 2006 Aug 10;24(23):3726-34
pubmed: 16720680
J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64
pubmed: 21960707
PLoS One. 2013 Jun 27;8(6):e68252
pubmed: 23826382
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
Breast Cancer Res Treat. 2011 Apr;126(3):797-802
pubmed: 21197567
J Oncol Pract. 2017 Dec;13(12):784-790
pubmed: 29232539
Eur J Cancer. 2016 Oct;66:104-13
pubmed: 27544930
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
BMC Cancer. 2017 Apr 13;17(1):265
pubmed: 28407750
Ann Oncol. 2017 Aug 1;28(8):1700-1712
pubmed: 28838210
NPJ Breast Cancer. 2017 Sep 8;3:33
pubmed: 28900633
PLoS One. 2012;7(5):e37379
pubmed: 22662150
Breast Cancer Res Treat. 2017 Oct;165(3):573-583
pubmed: 28664507
Breast. 2019 Apr;44:39-45
pubmed: 30634106
Lancet Oncol. 2010 Jan;11(1):55-65
pubmed: 20005174
NPJ Breast Cancer. 2017 Sep 8;3:32
pubmed: 28900632
Br J Cancer. 2014 Aug 26;111(5):837-42
pubmed: 25003667
Breast. 2017 Jun;33:191-199
pubmed: 28441617